Publication Catalogue

Publications of the Department of Turku 2001

A. Original articles and reviews

  1. Alitalo A, Meri T, Rämö L, Jokiranta TS, Heikkilä T, Seppälä IJT, Oksi J, Viljanen M, Meri S: Complement Evasion by Borrelia burgdorferi: Serum-Resistant Strains Promote C3b Inactivation. Infect Immun 2001;69:3685-3691.
  2. Buchholz U, Bronzwaer SLAM, Schrijinemakers P, Monen J, Kool JL, EARSS : EARSS activities and results: update. EuroSurveillance 2001;6:2-5.
  3. Campins-Martí M, Cheng HK, Forsyth K, Guiso N, Halperin S, Huang L, Mertsola J, Oselka G, Ward J, Wirsing KCH, Zepp F: Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine 2001;20:641-646.
  4. Fendler C, Laitko S, Sörensen H, Gripenberg-Lerche C, Groh A, Uksila J, Granfors K, Braun J, Sieper J: Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis 2001;60:337-343.
  5. Hakanen A, Kotilainen P, Huovinen P, Helenius H, Siitonen A: Reduced fluoroguinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerging Infectious Diseases 2001;7:996-1003.
  6. He F, Tuomola E, Arvilommi H, Salminen S: Modulation of human humoral immune response through orally administered bovine colostrum. Fems Immunol Med Microbiol 2001;31:93-96.
  7. Huovinen P: Bacteriotherapy: the time has come. BMJ 2001;323:353-354.
  8. Huovinen P: Fight Against Bacterial Resistance: Time for Action. Epinorth 2001;2:3-5.
  9. Huovinen P: Resistance to Trimethoprim-Sulfamethoxazole. Clin Infect Dis 2001;32:1608-1614.
  10. Irjala H, Johansson E, Grenman R, Alanen K, Salmi M, Jalkanen S: Mannose Receptor Is a Novel Ligand for L-Selectin and Mediates Lymphocyte Binding to Lymphatic Endothelium. J Exp Med 2001;194:1033-1041.
  11. Irjala H, Salmi M, Alanen K, Grénman R, Jalkanen S: Vascular Adhesion Protein 1 Mediates Binding of Immunotherapeutic Effector Cells to Tumor Endothelium. J Immunol 2001;166:6937-6943.
  12. Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S: Probiotics: effects on immunity. Am J Clin Nutr 2001;73(2 Suppl):444S-450S.
  13. Jalava J, Kataja J, Seppälä H, Huovinen P: In Vitro Activities of the Novel Ketolide Telithromycin (HMR 3647) against Erythromycin-Resistant Streptococcus Species. Antimicrob Agents Chemother 2001;45:789-793.
  14. Jalkanen K, Leu T, Bono P, Salmi M, Jalkanen S, Smith DJ: Distinct ligand binding properties of Mac-2-binding protein and mousephilin C-associated protein. Eur J Immunol 2001;31:3075-3084.
  15. Jalkanen S, Salmi M: Cell surface monoamine oxidases: enzymes in search of a function. EMBO J 2001;20:3893-3901.
  16. Jones RN, Hare RS, Sabatelli FJ, the Ziracin Suspceptibility Testing Group: In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: a multicentre international trial. J Antimicrob Chemother 2001;47:15-25.
  17. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E: Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076-1079.
  18. Kaluza W, Leirisalo-Repo M, Märker-Hermann E, Westman P, Reuss E, Hug R, Mastrovic K, Stradmann-Bellinghausen B, Granfors K, Galle PR, Höhler T: IL10.G Microsatellites Mark Promoter Haplotypes Associated With Protection Against the Development of Reactive Arthritis in Finnish Patients. Arthritis Rheum 2001;44:1209-1214.
  19. Kurkijärvi R, Jalkanen S, Isoniemi H, Salmi M: Vascular adhesion protein-1 (VAP-1) mediates lymphocyte-endothelial interactions in chronic kidney rejection. Eur J Immunol 2001;31:2876-2884.
  20. Leistevuo J, Leistevuo T, Helenius H, Pyy L, Österblad M, Huovinen P, Tenovuo J: Dental Amalgam Fillings and the Amount of Organic Mercury in Human Saliva. CARIES RES 2001;35:163-166.
  21. Liu Y, Li J, Chen B, Helenius H, Granfors K: Familial Aggregation of Ankylosing Spondylitis in Southern China. J Rheumatol 2001;28:550-553.
  22. Liu Y, Penttinen MA, Granfors K: Insights into the Role of Infection in the Spondyloarthropathies. Current Rheumatology Reports 2001;3:428-434.
  23. Maula S, Huuhtanen RL, Blomqvist CP, Wiklund TA, Laurila P, Ristamäki R: The adhesion molecule CD44v6 is associated with a high risk for local recurrence in adult soft tissue sarcomas. Br J Cancer 2001;84:244-252.
  24. Mäkinen J, Marttila H, Viljanen MK: Automated purification of Borrelia burgdorferi s.l. PCR products with KingFisherTM magnetic particle processor prior to genome sequencing. Journal of Magnetism and Magnetic Materials 2001;225:134-137.
  25. Mäkinen J, Viljanen MK, Mertsola J, Arvilommi H, He Q: Rapid Identification of Bordetella pertussis Pertactin Gene Variants Using LightCycler Real-Time Polymerase Chain Reaction Combined with Melting Curve Analysis and Gel Electrophoresis. Emerging Infectious Diseases 2001;7:941-947.
  26. Oksi J, Marttila H, Soini H, Aho H, Uksila J, Viljanen MK: Early dissemination of Borrelia burgdorferi without generalized symptoms in patients with erythema migrans. APMIS 2001;109:581-588.
  27. Paavilainen T, Alanen M, Mäkelä M, Routamaa M, Järvinen H, Huovinen P, Kotilainen P: Infrequent Isolation of Multiresistant Acinetobacter baumannii From the Staff Tending a Colonized Patient With Severe Burns. INFECT CONTROL HOSP EPIDEMIOL 2001;22:388-391.
  28. Pihlajamäki M, Kotilainen P, Kaurila T, Klaukka T, Palva E, Huovinen P, the Finnish Study Group for Antimicrobial Resistance: Macrolide-Resistant Streptococcus pneumoniae and Use of Antimicrobial Agents. Clin Infect Dis 2001;33:483-488.
  29. Rantakokko-Jalava K, Jalava J: Development of Conventional and Real-Time PCR Assays for Detection of Legionella DNA in Respiratory Specimens. J Clin Microbiol 2001;39:2904-2910.
  30. Rantakokko-Jalava K, Marjamäki M, Marttila H, Mäkelä L, Valtonen V, Viljanen MK: LCx Mycobacterium tuberculosis assay is valuable with respiratory specimens, but provides little help in the diagnosis of extrapulmonary tuberculosis. Ann Med 2001;33:55-62.
  31. Rautakorpi U, Klaukka T, Honkanen P, Mäkelä M, Nikkarinen T, Palva E, Roine R, Sarkkinen H, Huovinen P: Antibiotic Use by Indication: A Basis for Active Antibiotic Policy in the Community. Scand J Infect Dis 2001;33:920-926.
  32. Salmi M, Alanen K, Grenman S, Briskin M, Butcher EC, Jalkanen S: Immune Cell Trafficking in Uterus and Early Life Is Dominated by the Mucosal Addressin MAdCAM-1 in Humans. Gastroenterology 2001;121:853-864.
  33. Salmi M, Jalkanen S: Human Leukocyte Subpopulations from Inflamed Gut Bind to Joint Vasculature Using Distinct Sets of Adhesion Molecules. J Immunol 2001;166:4650-4657.
  34. Salmi M, Jalkanen S: VAP-1: an adhesin and an enzyme. Trends in Immunology 2001;22:211-216.
  35. Salmi M, Yegutkin GG, Lehvonen R, Koskinen K, Salminen T, Jalkanen S: A Cell Surface Amine Oxidase Directly Controls Lymphocyte Migration. IMMUNITY 2001;14:265-276.
  36. Salminen S, Arvilommi H: Probiotics Demonstrating Efficacy in Clinical Settings. Clin Infect Dis 2001;32:1577-1578.
  37. Seta N, Granfors K, Sahly H, Kuipers JG, Song YW, Baeten D, Veys EM, Maksymowych W, Märker-Hermann E, Gu J, Huang F, Kirveskari J, Yu DTY: Expression of Host Defense Scavenger Receptors in Spondylarthropathy. Arthritis Rheum 2001;44:931-939.
  38. Soini H, Musser JM: Molecular Diagnosis of Mycobacteria. Clin Chem 2001;47:809-814.
  39. Tohka S, Laukkanen M, Jalkanen S, Salmi M: Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo. FASEB J 2001;15:373-382.
  40. Yegutkin GG, Henttinen T, Jalkanen S: Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions. FASEB J 2001;15:251-260.
  41. Österblad M, Norrdahl K, Korpimäki E, Huovinen P: How wild are wild mammals? Nature 2001;409:37-38.

B. Original articles and reviews published in domestic languages

  1. Huovinen P, FiRe - Finnish Study Group for Antimicrobial Resistance: Virtsan E. coli -bakteerien resistenssitilanne. 2001. (Kansanterveys 2001(2):2-3).
  2. Huovinen P, FiRe - Finnish Study Group for Antimicrobial Resistance: Hengitystiepatogeenien resistenssitilanne. Kansanterveys - the Bulletin of National Public Health Institute of Finland 2001;1:10-11.
  3. Huovinen P, Hatakka A, Hiltunen M, Jalava J, Nevalainen A, Pietinen P, Salminen S, Vanhanen S: Mikrobit ja ihminen - kohti ymmärtävää kumppanuutta. Suom Lääkäril 2001;56:2916-2919.
  4. Klaukka T, Huovinen P, Palva E: Mikrobilääkkeiden käyttö pysyttelee vakaana. Suom Lääkäril 2001;56:4632-4634.
  5. Oksi J, Marttila H, Soini H, Aho H, Uksila J, Viljanen M: Erythema migrans Turunmaan saariston asukkailla. Suom Lääkäril 2001;43:4381-4385.

E. Theses

  1. Henttinen T: Role of soluble mediators in leukocyte activation and adhesion to the endothelium: special emphasis on cytokine and purine mediated pathways [dissertation]. Turku: Turun Yliopisto, 2001. 92 p. (Sarja D Medica - Odontoligica osa 466/2001).
  2. Tohka S: Leukocyte adhesion to endothelium in vitro and in vivo: role of vascular adhesion protein-1 (VAP-1) [dissertation]. Turku: Turun Yliopisto, 2001. 137 p. (Sarja D Medica - Odontologica osa 463/2001).